Metabolite control of angiogenesis: Angiogenic effect of citrate

Journal of Physiology and Biochemistry

Volumn 69, Issue 3, 2013, Pages 383-395

  Binu, S ^a   Soumya, S J ^a   Sudhakaran, P R ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

Angiogenesis; Aortic ring assay; Chorioallantoic membrane assay; Citrate; Vascular endothelial growth factor

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD31 ANTIGEN; CITRIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBROBLAST GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; VASCULOTROPIN; WORTMANNIN;

AKT KINASE ASSAY; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CHORIOALLANTOIS; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; METABOLIC REGULATION; NONHUMAN; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR RING; VASCULARIZATION; WESTERN BLOTTING;

RATTUS;

EID: 84892825313     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-012-0220-9     Document Type: Article

References (33)

1. Bluml S, Panigrahy A, Laskov M, Dhall G, Krieger MD, Nelson MD, Finlay JL, Gilles F (2011) Elevated citrate in pediatric astrocytomas with malignant progression. Neuro Oncol 13:1107-1117
2. Briere JJ, Favier J, Gimenez-Roqueplo AP, Rustin P (2006) Tricarboxylic acid cycle dysfunction as a cause of human disease and tumor formation. Am J Physiol Cell Physiol 29:C1114-1120
3. Busch H, David JR, Olle WE (1957) Citrate accumulation in slices of transplantable tumors of rats. Cancer Res 17:711-716
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029-1039
5. Engvall E, Perlman P (1971) Enzyme-linked immunosorbent assay (ELISA): quantitative assay of immunoglobulin. Immunochem 8:871-874
6. Ferrara N (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36:127-137
7. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1:27-31
8. Foster KG, Fingar DC (2010) Mammalian target of rapamycin (mTOR): conducting cellular symphony. J Biol Chem 285:14071-14077
9. Fraisl P, Mazzone M, Schmidt T, Carmeliet P (2009) Regulation of angiogenesis by oxygen and metabolism. Dev Cell 16:168-179
10. Hatzirassiliou G, Zhoa F, Bauer E, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8:311-321
11. Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ (2002) Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 16:771-780
12. Kaper F, Dornhoefer N, Giaccia AJ (2006) Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions. Cancer Res 66:1561-1569
13. Kiran MS, Kumar VB, Viji RI, Sherin GT, Rajasekharan KN, Sudhakaran PR (2008) Opposing effects of curcuminoids on serum stimulated and unstimulated angiogenic response. J Cell Physiol 215:251-264
14. Kumar VB, Viji RI, Kiran MS, Sudhakaran PR (2007) Endothelial cell response to lactate: implications of PAR modification of VEGF. J Cell Physiol 211:477-485
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
16. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/AKT signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90:3322-3331
17. Murray B, Wilson DJ (2001) A study of metabolites as intermediate effectors in angiogenesis. Angiogenesis 4:71-77
18. Mycielska ME, Broke-Smith TP, Palmer CP, Beckerman R, Nastos T, Erguler K, Djamgoz MB (2006) Citrate enhances in vitro metastatic behaviours of PC-3 M human prostate cancer cells: Status of endogenous citrate and dependence on aconitase and fatty acid synthase. Int J Biochem Cell Biol 38:1766-1777
19. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor and its receptors. FASEB J 13:9-22
20. Nicosia RF, Ottinetti A (1990) Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab Invest 63:115-122
21. Nugent MA, Lozzo RV (2000) Fibroblast growth factor-2. Int J Biochem Cell Biol 32:115-120
22. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79:315-328
23. Petrova TV, Makinen T, Alitalo K (1999) Signaling via vascular endothelial growth factor receptors. Exp Cell Res 253:117-130
24. Roberts DD (1996) Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 10:1183-1191
25. Schlessinger J, Lax I, Lemmon M (1995) Regulation of growth factor activation by proteoglycans: what is the role of low affinity receptors?Cell 83:357-360
26. Seymer ZA, Panigrahy A, Finlay JL, Nelson MD Jr, Bluml S (2008) Citrate in pediatric CNS tumors? Am J Neuroradiol 29:1006-1011
27. Sheibani N, Frazier WA (1998) Downregualtion of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell 9:701-713
28. Singh KK, Desouki MM, Franklin RB, Costello LC (2006) Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissue. Mol Can 5:14-21
29. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
30. Viji RI, Kumar VB, Kiran MS, Sudhakaran PR (2008) Angiogenic response of endothelial cells to heparin binding domain of fibronectin. IJBCB 40:215-226
31. Wise DR, Ward PS, Shay J E S, Cross JR, Grober JJ, Sachdeva UM, Platt JM, De Matteo S M C, Thompson CB (2011) Hypoxia promotes isocitrate dehyrogenase dependent carboxylation of α ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci USA 108:19611-19616
32. Zhang B, Cao H, Rao GN (2005) 15 (S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling. Cancer Res 16:7283-7291
33. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL (2000) Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541-1545